Company: NBRG
Filing Date: 2025-09-25
Form Type: S-1/A
Source: 0001213900-25-091531
Chunk: 72

Company: Newbridge Acquisition Ltd
Filing Date: 2025-09-25
Form: S-1/A
Chunk 72
---
 may be less than $10.00 per share” on page 86. 39 •The sponsor has paid an aggregate of $25,000, or approximately $0.017 per founder share (assuming over -allotmentoption will be exercised) and, accordingly, you will experience immediate and substantial dilution from the purchase of our ordinary shares. See “Risk Factors — The sponsor has paid an aggregate of $25,000, or approximately $0.017 per founder share (assuming over -allotment option will be exercised) and, accordingly, you will experience immediate and substantial dilution from the purchase of our ordinary shares” on page 88. •There is currently no market for our securities and a market for our securities may not develop, which would adversely affect the liquidity and price of our securities. See “Risk Factors — There is currently no market for our securities and a market for our securities may not develop, which would adversely affect the liquidity and price of our securities” on page 89. •Nasdaq may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions. See “Risk Factors — Once initially listed on Nasdaq, our securities may not continue to be listed on Nasdaq in the future, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions” beginning on page 89. •Holders of rights will not participate in liquidating distributions if we are unable to complete an initial business combination. See “Risk Factors — Holders of rights will not participate in liquidating distributions if we are unable to complete an initial business combination” beginning on page 90. •Trading in our securities may be prohibited under the HFCA Act if the PCAOB determines that it cannot inspect or fully investigate our auditor. In that case, Nasdaq would delist our securities. The delisting of our securities, or the threat of their being delisted, may materially and adversely affect the value of your investment. Additionally, the inability of the PCAOB to conduct inspections may deprive our investors with the benefits of such inspections. See “Risk Factors — Trading in our securities may be prohibited under the HFCA Act if the PCAOB determines that it cannot inspect or fully investigate our auditor. In that case, Nasdaq would delist our securities. The delisting of our securities, or the threat of their being delisted, may materially and adversely affect the value of your investment. Additionally